Scleroderma Diagnostics and Therapeutics Market Scleroderma Diagnostics and Therapeutics Market - | Page 4

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2498
The global scleroderma therapeutics and diagnostics market has been segmented as follows:
Global Scleroderma Therapeutics Market, by Drug Class
 Corticosteroids
 Immunosuppressive Agents
 Endothelin Receptor Agonists
 Calcium Channel Blockers
 PDE-5 Inhibitors
 Chelating Agents
 Prostacyclin Analogues
 Others (H2 Blockers, Proton Pump Inhibitors, ACE Inhibitors etc.)
Global Scleroderma Therapeutics Market, by Indication
 Localized
 Systemic
Global Scleroderma Diagnostics Market, by Test Type
 Skin Biopsy
 Imaging Techniques
 Blood Tests
 Electrocardiogram and Echocardiogram
 Pulmonary Function Tests
Global Scleroderma Diagnostics and Therapeutics Market, by Geography
 North America
o U.S.
o Canada
 Asia Pacific
o India
o China
o Japan
o Rest of APAC
 Europe
o France
o Germany
o U.K.
o Rest of Europe
 Latin America
o Brazil
o Mexico
o Rest of Latin America
 Middle East & Africa
o UAE
o South Africa
o Rest of Middle East & Africa